Skip to Main Content

Paper Details

WWP1 inactivation enhances efficacy of PI3K inhibitors while suppressing their toxicities in breast cancer models.
Journal of Clinical Investigation
8
2021
Author NameAffiliation
Alex TokerBeth Israel Deaconess Medical Center, Harvard Medical School
Gerburg M WulfCancer Research Institute, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School
Kazuhiko KoikeGraduate School of Medicine, The University of Tokyo
  • 1 - 3

Datasets